Literature DB >> 32030271

Impact of diabetes mellitus on coagulation function before and after off-pump coronary artery bypass grafting.

Dawei Wang1, Yu Liu2, Ziying Chen2, Fei Yang3, Zhenming Zhang1, Yulei Wei1.   

Abstract

BACKGROUND: This study aims to explore the influence of off-pump coronary artery bypass grafting (OPCABG) on coagulation function and the effects of diabetes on coagulation function during OPCABG.
METHODS: Patients who met the inclusion and exclusion criteria were divided into two groups: diabetes mellitus (DM) and non-diabetes mellitus (NDM) groups. Thromboelastography (TEG) was tested at the following time points: T0, five days after aspirin and clopidogrel therapy, and before OPCABG; T1, returning to care unit after OPCABG; T2, 5 days after aspirin and clopidogrel therapy, and after OPCABG.
RESULTS: A total of 56 patients were involved. There were no deaths, or no early postoperative thrombotic events and abnormal bleeding after OPCABG. Intra-group comparison: Compared with T0, the R and K value decreased, while the α angle and MA value increased at T1 and T2, in both groups (P<0.05). A significantly statistical difference was found in the multiple comparison at T0, T1 and T2 (P<0.05). The results are as follows: the R value decreased at T1 and increased at T2, but the value remained less than that at T0. After the OPCABG, the K value gradually decreased, while the MA value and α angle gradually increased. Comparison between groups: T1: the R values were lower in the DM group, when compared to the NDM group (t=3.611, P=0.001). The differences in the MA, K and α angle were not statistically significant. T0 and T2: there were no statistically difference in the R, MA, K, α angle and LY30 between the two groups (P>0.05).
CONCLUSIONS: The coagulation function of patients was at a hypercoagulable state at the early stage after OPCABG. The coagulation function was affected by diabetes at the day of OPCABG. However, there was no statistical difference after 5 days of aspirin and clopidogrel therapy following OPCABG. 2019 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Coronary artery bypass grafting; coagulation function; diabetes mellitus (DM); off-pump coronary artery bypass grafting (OPCABG); thromboelastography (TEG)

Year:  2019        PMID: 32030271      PMCID: PMC6988029          DOI: 10.21037/jtd.2019.11.27

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

1.  Aspirin resistance in off-pump coronary artery bypass grafting.

Authors:  Zanxin Wang; Fei Gao; Jianlong Men; Jing Ren; Paul Modi; Minxin Wei
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

2.  Off-pump versus on-pump coronary artery bypass surgery in patients with actively treated diabetes and multivessel coronary disease.

Authors:  Umberto Benedetto; Massimo Caputo; Hunaid Vohra; Alan Davies; James Hillier; Alan Bryan; Gianni D Angelini
Journal:  J Thorac Cardiovasc Surg       Date:  2016-06-29       Impact factor: 5.209

3.  Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.

Authors:  Arie Pieter Kappetein; Stuart J Head; Marie-Claude Morice; Adrian P Banning; Patrick W Serruys; Friedrich-Wilhelm Mohr; Keith D Dawkins; Michael J Mack
Journal:  Eur J Cardiothorac Surg       Date:  2013-02-14       Impact factor: 4.191

4.  Early diagnosis of clinically significant hyperfibrinolysis using thrombelastography velocity curves.

Authors:  Matthew J Pommerening; Michael D Goodman; Danny L Farley; Jessica C Cardenas; Jeanette Podbielski; Nena Matijevic; Charles E Wade; John B Holcomb; Bryan A Cotton
Journal:  J Am Coll Surg       Date:  2014-10-08       Impact factor: 6.113

5.  Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling-Are Useful Drugs Already Available?

Authors:  Jane F Arthur; Karin Jandeleit-Dahm; Robert K Andrews
Journal:  Diabetes       Date:  2017-01       Impact factor: 9.461

6.  Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta).

Authors:  Eduardo Gonzalez; Jeffry L Kashuk; Ernest E Moore; Christopher C Silliman
Journal:  J Surg Res       Date:  2010-04-21       Impact factor: 2.192

Review 7.  The vulnerable blood. Coagulation and clot structure in diabetes mellitus.

Authors:  K Hess
Journal:  Hamostaseologie       Date:  2014-11-24       Impact factor: 1.778

8.  Off-pump coronary artery bypass surgery may produce a hypercoagulable patient.

Authors:  Robert L Quigley; David W Fried; John Pym; Richard Y Highbloom
Journal:  Heart Surg Forum       Date:  2003       Impact factor: 0.676

9.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

10.  Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.

Authors:  Michael P Vallely; Paul G Bannon; Matthew S Bayfield; Clifford F Hughes; Len Kritharides
Journal:  Heart Lung Circ       Date:  2008-12-09       Impact factor: 2.975

View more
  1 in total

1.  The Effect of Off-Pump Coronary Artery Bypass Grafting in Patients on Aspirin Therapy until Surgery Day.

Authors:  Zhishuo Liu; Zhonglu Yang; Yuguang Ge; Lu Wang; Hui Jiang
Journal:  Contrast Media Mol Imaging       Date:  2022-07-08       Impact factor: 3.009

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.